Advertisement
Screener

ASSERTIO THERAPEUTICS, INC. Proceeds from Convertible Debt

ASSERTIO THERAPEUTICS, INC. Proceeds from Convertible Debt

ASSERTIO THERAPEUTICS, INC. reported Proceeds from Convertible Debt of $345.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-24.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromConvertibleDebt · last filed 2017-02-24

  • ASSERTIO THERAPEUTICS, INC. proceeds from convertible debt for the quarter ending 2014-12-31 was $0.00.
  • ASSERTIO THERAPEUTICS, INC. proceeds from convertible debt for fiscal 2014 was $345.00M.
Period endProceeds from Convertible Debt 3 monthProceeds from Convertible Debt 9 monthProceeds from Convertible Debt 12 month
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$345.00M
10-K · filed 2017-02-24
2014-09-30$345.00M
10-Q · filed 2014-11-06